Cargando…
COVID-19 and NSAIDs: Primum non nocere
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375282/ https://www.ncbi.nlm.nih.gov/pubmed/32839015 http://dx.doi.org/10.1016/j.therap.2020.07.008 |
| _version_ | 1783561850660585472 |
|---|---|
| author | Micallef, Joëlle Soeiro, Thomas Jonville-Béra, Annie-Pierre |
| author_facet | Micallef, Joëlle Soeiro, Thomas Jonville-Béra, Annie-Pierre |
| author_sort | Micallef, Joëlle |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7375282 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73752822020-07-23 COVID-19 and NSAIDs: Primum non nocere Micallef, Joëlle Soeiro, Thomas Jonville-Béra, Annie-Pierre Therapie Letter to Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2020 2020-07-22 /pmc/articles/PMC7375282/ /pubmed/32839015 http://dx.doi.org/10.1016/j.therap.2020.07.008 Text en © 2020 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editor Micallef, Joëlle Soeiro, Thomas Jonville-Béra, Annie-Pierre COVID-19 and NSAIDs: Primum non nocere |
| title | COVID-19 and NSAIDs: Primum non nocere |
| title_full | COVID-19 and NSAIDs: Primum non nocere |
| title_fullStr | COVID-19 and NSAIDs: Primum non nocere |
| title_full_unstemmed | COVID-19 and NSAIDs: Primum non nocere |
| title_short | COVID-19 and NSAIDs: Primum non nocere |
| title_sort | covid-19 and nsaids: primum non nocere |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375282/ https://www.ncbi.nlm.nih.gov/pubmed/32839015 http://dx.doi.org/10.1016/j.therap.2020.07.008 |
| work_keys_str_mv | AT micallefjoelle covid19andnsaidsprimumnonnocere AT soeirothomas covid19andnsaidsprimumnonnocere AT jonvilleberaanniepierre covid19andnsaidsprimumnonnocere |